Albert David Limited (NSE:ALBERTDAVD)
India · Delayed Price · Currency is INR 687.00
-9.30 (-1.34%)
Jul 22, 2026, 3:29 PM IST
Albert David Market Cap
Albert David has a market cap or net worth of 3.95 billion as of July 22, 2026. Its market cap has decreased by -24.61% in one year.
Market Cap
3.95B
Enterprise Value
1.67B
Revenue
3.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
687.00
ChartMarket Cap Chart
Since October 30, 2001, Albert David's market cap has increased from 80.47M to 3.95B, an increase of 4,814.54%. That is a compound annual growth rate of 17.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 3.93B | -7.00% |
| Dec 31, 2025 | 4.22B | -44.14% |
| Dec 31, 2024 | 7.56B | 35.71% |
| Dec 29, 2023 | 5.57B | 71.95% |
| Dec 30, 2022 | 3.24B | -6.10% |
| Dec 31, 2021 | 3.45B | 36.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Windlas Biotech | 18.17B |
| Jagsonpal Pharmaceuticals | 14.91B |
| Sigachi Industries | 9.95B |
| Bafna Pharmaceuticals | 5.53B |
| Valiant Laboratories | 3.42B |
| Nectar Lifesciences | 2.08B |
| Brooks Laboratories | 1.95B |
| Alpa Laboratories | 1.42B |